InvestorsHub Logo

Skeetz99

08/19/13 11:28 AM

#81023 RE: Solantey #81022

Good points! Its OK to dream as any possible scenario could unfold at any given time.

I think the 10-Q was delayed this time around for the right reasons; it will more than likely include some timely and critical information. GLTA!!!

Driven30

08/19/13 12:35 PM

#81032 RE: Solantey #81022

Very exciting times indeed, in the next several weeks I think it could possibly drop big time or hit a $1 or higher like you said. Lets hope for the latter. I think people like Dr. Rubenfeld have better things to do than be part of a penny stock scam.

gz69

08/19/13 1:01 PM

#81037 RE: Solantey #81022

I share your view.

The other option is that LymPro is licensed by Becton Dickinson and the share price moves above $1.00 and then Amgen enters into a license agreement to develop MANF and the share price moves over $5.00.

This doesn't happen to thousands of companies but it may well happen to "$AMBS".



I a bit of a history buff and therefore goes back and watch previous video clips of AMBS. The January OneMedForumSF 2013 was worth watching closely. This was a detailed scientific presentation.

I have no doubt the business strategies are brilliant...play out several fishing lines and get the revenue from Lympro and finance MANF.

There is no hype nor high pitch salesmanship in Gerald in all his video interviews and presentations. A quiet assertion on what he and his father firmly believe in. The challenges are there for sure but I see the commitment and the passion. I vote with my wallet.